P51. Identification of prostate cancer-associated antigens by oxygen manipulation

by Ma, T, Elkhattouti, A, Kosari, F, Karnes, RJ, Cheville, JC, Vasmatzis, G, Vuk-Pavlovic, S, Gomez, RC
Published 2014

Chromoplectic TPM3–ALK rearrangement in a patient with inflammatory myofibroblastic tumor who responded to ceritinib after progression on crizotinib

by Mansfield, A. S., Murphy, S. J., Harris, F. R., Robinson, S. I., Marks, R. S., Johnson, S. H., Smadbeck, J. B., Halling, G. C., Yi, E. S., Wigle, D., Vasmatzis, G., Jen, J.
Published 2016

Somatic rearrangement of the TP63 gene preceding development of mycosis fungoides with aggressive clinical course

by Chavan, R N, Bridges, A G, Knudson, R A, Ketterling, R P, Comfere, N, Wada, D A, Torres-Cabala, C, DiCaudo, D J, Vasmatzis, G, Pittelkow, M R, Feldman, A L
Published 2014

Activation of TAK1 by MYD88 L265P drives malignant B-cell Growth in non-Hodgkin lymphoma

by Ansell, S M, Hodge, L S, Secreto, F J, Manske, M, Braggio, E, Price-Troska, T, Ziesmer, S, Li, Y, Johnson, S H, Hart, S N, Kocher, J-P A, Vasmatzis, G, Chanan-Kahn, A, Gertz, M, Fonseca, R, Dogan, A, Cerhan, J R, Novak, A J
Published 2014